Cancer Diagnostics – Products

Whitepaper
Sensitive DNA Methylation Detection Using Droplet Digital PCR
This whitepaper demonstrates how common methylation detection methods can be combined with Droplet Digital PCR (ddPCR) to enhance the cfDNA analysis for clinical and research applications.

App Note / Case Study
FFPE Sample Prep Advancements To Transform Solid Tumor Treatment
This case study presents a scalable, automation-friendly workflow for active deparaffinization, extraction and purification of nucleic acids from FFPE samples that can transform cancer diagnostics as demand grows.

Product News
Bio-Rad Launches Celselect Slides 2.0 To Advance Rare Cell and Circulating Tumor Cell Enrichment for Cancer Research
New Celselect slides™ design increases efficiency of circulating tumor cell capture from liquid biopsy samples for enumeration and downstream applications.

App Note / Case Study
Smarter Fusion Detection for Cancer Diagnostics
This app note highlights a robust targeted RNA enrichment workflow that integrates automation to expedite library preparation and data analysis.

Product News
Aptamer and Timser Partner To Deliver World’s First Blood Test for Cervical Cancer
Optimer binders will be developed for use in a cervical cancer blood test. Agreement for up to £465,000 signed for Optimer development.

Product
Advertisement
Reveal the Power of the 6-Base Genome With duet multiomics solution evoC
Distinguish 5mC & 5hmC together with all 4 canonical bases to measure multiple modes of biology from a 5ng cfDNA sample in a single experiment. Identify new multimodal biomarkers to gain transformative insight into current & future states of disease.

Product News
Bio-Rad Announces Collaboration Agreement With Oncocyte To Commercialize Transplant Monitoring With Droplet Digital PCR
Collaboration aims to provide researchers cutting-edge tools to enable transformational monitoring of key biomarkers in solid tissue transplants.

Product News
Bio-Rad and Allegheny Health Network Cancer Institute collaborate to advance personalized monitoring of solid tumor cancers with droplet digital PCR
Collaboration aims to grow clinical evidence supporting the use of bio-Rad’s ddPCR™ technology for molecular residual disease monitoring of patients across a range of solid tumor types.

Product News
Bio-Rad Launches First Ultrasensitive Multiplexed Digital PCR Assay for Breast Cancer Mutation Detection
Highly sensitive and multiplexed assay for the detection, discrimination, and quantification of key mutations in ESR1 gene for breast cancer, developed for bio-Rad’s QX600™ droplet digital™ PCR system.

Product News
Bio-Rad Launches Validated Antibodies for Rare Cell and Circulating Tumor Cell Enumeration
Antibodies validated for use with bio-Rad’s Celselect slides™ enumeration stain kits to enable immunostaining of captured circulating tumor cells in liquid biopsy samples.
Advertisement